Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome: Target Trial Emulation Study.

RecruitingOBSERVATIONAL

Enrollment

100,000

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Coronary Artery Disease

Interventions

DRUG

Routine use of P-CAB on DAPT

This group received P-CAB with DAPT after PCI.

DRUG

Guideline Directed Medical Therapy

This group received PPI or not with DAPT after PCI according to GI bleeding risk.

Trial Locations (1)

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors

lead

Samsung Medical Center

OTHER